{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:10:20Z","timestamp":1778721020301,"version":"3.51.4"},"reference-count":92,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.humimm.2023.03.002","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T03:17:56Z","timestamp":1678763876000},"page":"393-400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Peripheral HLA-G\/ILT-2 immune checkpoint axis in acute and convalescent COVID-19 patients"],"prefix":"10.1016","volume":"84","author":[{"given":"Hana","family":"Rohn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krystallenia","family":"Pansikaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celina","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Platte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarethe J.","family":"Konik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Dolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Wilde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lambros","family":"Kordelas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirko","family":"Trilling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adalbert","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Witzke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Rebmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.humimm.2023.03.002_b0005","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00018-022-04359-2","article-title":"The HLA-G immune checkpoint: a new immuno-stimulatory role for the alpha1-domain-deleted isoform","volume":"79","author":"Tronik-Le Roux","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.humimm.2023.03.002_b0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.imlet.2011.02.011","article-title":"The tolerogenic molecule HLA-G","volume":"138","author":"Carosella","year":"2011","journal-title":"Immunol. Lett."},{"issue":"3","key":"10.1016\/j.humimm.2023.03.002_b0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s000180050295","article-title":"Immunotolerant functions of HLA-G","volume":"55","author":"Carosella","year":"1999","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.humimm.2023.03.002_b0020","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00018-010-0583-4","article-title":"Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?","volume":"68","author":"Amiot","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.humimm.2023.03.002_b0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/10408363.2012.677947","article-title":"The immunosuppressive molecule HLA-G and its clinical implications","volume":"49","author":"Gonzalez","year":"2012","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"10","key":"10.1016\/j.humimm.2023.03.002_b0030","doi-asserted-by":"crossref","first-page":"e71742","DOI":"10.1371\/journal.pone.0071742","article-title":"Polymorphic sites at the 3' untranslated region of the HLA-G gene are associated with differential hla-g soluble levels in the Brazilian and French population","volume":"8","author":"Martelli-Palomino","year":"2013","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1016\/j.humimm.2023.03.002_b0035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1399-0039.2006.763_5.x","article-title":"Quantification and identification of soluble HLA-G isoforms","volume":"69","author":"Rebmann","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2023.03.002_b0040","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3389\/fimmu.2020.01178","article-title":"HLA-G genotype\/expression\/disease association studies: success, hurdles, and perspectives","volume":"11","author":"Amodio","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2023.03.002_b0045","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.3389\/fimmu.2020.02046","article-title":"Soluble HLA-G and HLA-G bearing extracellular vesicles affect ILT-2 positive and ILT-2 negative CD8 T cells complementary","volume":"11","author":"Schwich","year":"2020","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.humimm.2023.03.002_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081106","article-title":"Vesicular-bound HLA-G as a predictive marker for disease progression in epithelial ovarian cancer","volume":"11","author":"Schwich","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.humimm.2023.03.002_b0055","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/eji.201343318","article-title":"In vivo identification of an HLA-G complex as ubiquitinated protein circulating in exosomes","volume":"43","author":"Alegre","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.humimm.2023.03.002_b0060","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.humimm.2016.01.002","article-title":"The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients","volume":"77","author":"Konig","year":"2016","journal-title":"Hum. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2023.03.002_b0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/tan.12844","article-title":"Soluble monomers, dimers and HLA-G-expressing extracellular vesicles: the three dimensions of structural complexity to use HLA-G as a clinical biomarker","volume":"88","author":"Nardi Fda","year":"2016","journal-title":"HLA"},{"issue":"8","key":"10.1016\/j.humimm.2023.03.002_b0070","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.humimm.2007.04.007","article-title":"Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy: longitudinal study during pregnancy","volume":"68","author":"Alegre","year":"2007","journal-title":"Hum. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2023.03.002_b0075","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00018-010-0579-0","article-title":"The role of HLA-G in immunity and hematopoiesis","volume":"68","author":"Carosella","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.humimm.2023.03.002_b0080","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.humimm.2021.01.003","article-title":"Role of the HLA-G immune checkpoint molecule in pregnancy","volume":"82","author":"Rouas-Freiss","year":"2021","journal-title":"Hum. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2023.03.002_b0085","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0165-0378(99)00037-6","article-title":"HLA-G expression in human melanoma cells: protection from NK cytolysis","volume":"43","author":"Adrian Cabestre","year":"1999","journal-title":"J. Reprod. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2023.03.002_b0090","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.4049\/jimmunol.176.3.1331","article-title":"Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes","volume":"176","author":"Bahri","year":"2006","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.humimm.2023.03.002_b0095","doi-asserted-by":"crossref","first-page":"7054","DOI":"10.4049\/jimmunol.0803054","article-title":"Dendritic cells secrete the immunosuppressive HLA-G molecule upon CTLA4-Ig treatment: implication in human renal transplant acceptance","volume":"183","author":"Bahri","year":"2009","journal-title":"J. Immunol."},{"issue":"25","key":"10.1016\/j.humimm.2023.03.002_b0100","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1182\/blood-2011-07-370742","article-title":"The tolerogenic interplay(s) among HLA-G, myeloid APCs, and regulatory cells","volume":"118","author":"Carosella","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2023.03.002_b0105","article-title":"Inhibition of iNKT cells by the HLA-G-ILT2 checkpoint and poor stimulation by HLA-G-expressing tolerogenic DC","volume":"11","author":"Wu","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2023.03.002_b0110","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/14653240802105299","article-title":"A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells","volume":"10","author":"Rizzo","year":"2008","journal-title":"Cytotherapy"},{"issue":"5","key":"10.1016\/j.humimm.2023.03.002_b0115","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.trecan.2021.01.004","article-title":"HLA-G\/LILRBs: a cancer immunotherapy challenge","volume":"7","author":"Carosella","year":"2021","journal-title":"Trends Cancer"},{"issue":"4","key":"10.1016\/j.humimm.2023.03.002_b0120","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.humimm.2020.02.001","article-title":"Cytometry-based analysis of HLA-G functions according to ILT2 expression","volume":"81","author":"Jacquier","year":"2020","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2023.03.002_b0125","doi-asserted-by":"crossref","first-page":"4829227","DOI":"10.1155\/2022\/4829227","article-title":"Effect of HLA-G5 immune checkpoint molecule on the expression of ILT-2, CD27, and CD38 in splenic B cells","volume":"2022","author":"Rohn","year":"2022","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.humimm.2023.03.002_b0130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/bs.ai.2015.04.001","article-title":"HLA-G: an immune checkpoint molecule","volume":"127","author":"Carosella","year":"2015","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.humimm.2023.03.002_b0135","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/297073","article-title":"HLA-G as a tolerogenic molecule in transplantation and pregnancy","volume":"2014","author":"Rebmann","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.humimm.2023.03.002_b0140","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3389\/fimmu.2016.00173","article-title":"The potential of HLA-G-bearing extracellular vesicles as a future element in HLA-G immune biology","volume":"7","author":"Rebmann","year":"2016","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2023.03.002_b0145","first-page":"93","article-title":"HLA-G promotes immune tolerance","volume":"14","author":"Rouas-Freiss","year":"2000","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.humimm.2023.03.002_b0150","first-page":"465","article-title":"The non-classical antigens of HLA-G and HLA-E as diagnostic and prognostic biomarkers and as therapeutic targets in transplantation and tumors","author":"Seliger","year":"2013","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.humimm.2023.03.002_b0155","article-title":"Systematic evaluation of HLA-G 3'Untranslated region variants in locally advanced, non-metastatic breast cancer patients: UTR-1, 2 or UTR-4 are predictors for therapy and disease outcome","volume":"12","author":"Rebmann","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2023.03.002_b0160","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.humimm.2019.09.011","article-title":"HLA-G 3' untranslated region gene variants are promising prognostic factors for BK polyomavirus replication and acute rejection after living-donor kidney transplant","volume":"81","author":"Rohn","year":"2020","journal-title":"Hum. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2023.03.002_b0165","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1038\/s41598-019-41900-z","article-title":"HLA-G 3' untranslated region variants +3187G\/G, +3196G\/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancer","volume":"9","author":"Schwich","year":"2019","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.humimm.2023.03.002_b0170","first-page":"4460","article-title":"HLA-G is a potential tumor marker in malignant ascites","volume":"9","author":"Singer","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.humimm.2023.03.002_b0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112338","article-title":"Recipient HLA-G +3142 CC genotype and concentrations of soluble HLA-G impact on occurrence of CMV infection after living-donor kidney transplantation","volume":"18","author":"Guberina","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2023.03.002_b0180","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.actatropica.2019.04.026","article-title":"HLA-G expression during hookworm infection in pregnant women","volume":"196","author":"Avokpaho","year":"2019","journal-title":"Acta Trop."},{"issue":"5","key":"10.1016\/j.humimm.2023.03.002_b0185","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.healun.2022.01.013","article-title":"Chronic lung allograft dysfunction is associated with an early increase of circulating cytotoxic CD4+CD57+ILT2+ T cells, selectively inhibited by the immune check-point HLA-G","volume":"41","author":"Brugiere","year":"2022","journal-title":"J. Heart Lung Transpl."},{"issue":"7","key":"10.1016\/j.humimm.2023.03.002_b0190","doi-asserted-by":"crossref","first-page":"e645","DOI":"10.1002\/iid3.645","article-title":"The relationship of 3'UTR HLA-G14-bp insertion\/deletion and +3142 C\/G polymorphisms and soluble HLA-G expression with gynecological cancers: an updated meta-analysis","volume":"10","author":"Tizaoui","year":"2022","journal-title":"Immun. Inflamm. Dis."},{"issue":"6","key":"10.1016\/j.humimm.2023.03.002_b0195","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.semcancer.2007.06.010","article-title":"HLA-G expression in malignant melanoma","volume":"17","author":"Rebmann","year":"2007","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.humimm.2023.03.002_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108482","article-title":"HLA-G liver expression and HLA-G extended haplotypes are associated with chronic hepatitis C in HIV-negative and HIV-coinfected patients","volume":"217","author":"Bertol","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.humimm.2023.03.002_b0205","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.826074","article-title":"Role of HLA-G in viral infections","volume":"13","author":"Jasinski-Bergner","year":"2022","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.humimm.2023.03.002_b0210","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/jvh.12718","article-title":"Increased levels of soluble HLA-G molecules in Tunisian patients with chronic hepatitis B infection","volume":"24","author":"Laaribi","year":"2017","journal-title":"J. Viral Hepat."},{"issue":"10","key":"10.1016\/j.humimm.2023.03.002_b0215","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/jvh.12395","article-title":"Association of an HLA-G 14-bp Insertion\/Deletion polymorphism with high HBV replication in chronic hepatitis","volume":"22","author":"Laaribi","year":"2015","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.humimm.2023.03.002_b0220","doi-asserted-by":"crossref","first-page":"4326495","DOI":"10.1155\/2016\/4326495","article-title":"Recent advances in our understanding of HLA-G biology: lessons from a wide spectrum of human diseases","volume":"2016","author":"Morandi","year":"2016","journal-title":"J. Immunol. Res."},{"issue":"12","key":"10.1016\/j.humimm.2023.03.002_b0225","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.humimm.2020.10.001","article-title":"Puzzling out the COVID-19: therapy targeting HLA-G and HLA-E","volume":"81","author":"Zidi","year":"2020","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2023.03.002_b0230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.788769","article-title":"Perspective of HLA-G induced immunosuppression in SARS-CoV-2 infection","volume":"12","author":"Lin","year":"2021","journal-title":"Front. Immunol."},{"issue":"10224","key":"10.1016\/j.humimm.2023.03.002_b0235","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.humimm.2023.03.002_b0240","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.humimm.2023.03.002_b0245","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s13256-020-02551-1","article-title":"Detection of SARS-CoV-2 pneumonia: two case reports","volume":"14","author":"Seibert","year":"2020","journal-title":"J. Med. Case Rep."},{"issue":"1","key":"10.1016\/j.humimm.2023.03.002_b0250","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s15010-013-0509-9","article-title":"A patient with severe respiratory failure caused by novel human coronavirus","volume":"42","author":"Guberina","year":"2014","journal-title":"Infection"},{"issue":"8","key":"10.1016\/j.humimm.2023.03.002_b0255","article-title":"Cellular and humoral immunity against different SARS-CoV-2 variants is detectable but reduced in vaccinated kidney transplant patients","volume":"10","author":"Thummler","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.humimm.2023.03.002_b0260","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.960731","article-title":"The GNB3 c.825C>T (rs5443) polymorphism and protection against fatal outcome of corona virus disease 2019 (COVID-19)","volume":"13","author":"Mohlendick","year":"2022","journal-title":"Front. Genet."},{"issue":"2","key":"10.1016\/j.humimm.2023.03.002_b0265","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.jinf.2020.05.017","article-title":"Impacts of immunosuppression and immunodeficiency on COVID-19: a systematic review and meta-analysis","volume":"81","author":"Gao","year":"2020","journal-title":"J. Infect."},{"issue":"4","key":"10.1016\/j.humimm.2023.03.002_b0270","doi-asserted-by":"crossref","DOI":"10.3390\/v14040746","article-title":"COVID-19 in elderly, immunocompromised or diabetic patients-from immune monitoring to clinical management in the hospital","volume":"14","author":"Wunsch","year":"2022","journal-title":"Viruses"},{"issue":"19","key":"10.1016\/j.humimm.2023.03.002_b0275","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10194606","article-title":"Long-term SARS-CoV-2 specific immunity is affected by the severity of initial COVID-19 and patient age","volume":"10","author":"Konik","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.humimm.2023.03.002_b0280","doi-asserted-by":"crossref","first-page":"1031254","DOI":"10.3389\/fimmu.2022.1031254","article-title":"Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination","volume":"13","author":"Paniskaki","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2023.03.002_b0285","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.980698","article-title":"Long-term cellular immune response in immunocompromised unvaccinated COVID-19 patients undergoing monoclonal antibody treatment","volume":"13","author":"Thummler","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2023.03.002_b0290","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1002\/jmv.26840","article-title":"SARS-CoV-2-specific humoral and cellular immunity in two renal transplants and two hemodialysis patients treated with convalescent plasma","volume":"93","author":"Lindemann","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.humimm.2023.03.002_b0295","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.816220","article-title":"Immune response in moderate to critical breakthrough COVID-19 infection after mRNA vaccination","volume":"13","author":"Paniskaki","year":"2022","journal-title":"Front. Immunol."},{"issue":"7821","key":"10.1016\/j.humimm.2023.03.002_b0300","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.humimm.2023.03.002_b0305","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2023.03.002_b0310","doi-asserted-by":"crossref","first-page":"e1128","DOI":"10.1002\/cti2.1128","article-title":"Dynamics of peripheral immune cells and their HLA-G and receptor expressions in a patient suffering from critical COVID-19 pneumonia to convalescence","volume":"9","author":"Zhang","year":"2020","journal-title":"Clin. Transl. Immunol."},{"issue":"10","key":"10.1016\/j.humimm.2023.03.002_b0315","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.humimm.2021.07.007","article-title":"Soluble HLA-G is upregulated in serum of patients with severe COVID-19","volume":"82","author":"Al-Bayatee","year":"2021","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2023.03.002_b0320","article-title":"Evaluation of serum soluble HLA-G levels post-recovery from COVID-19 and post-vaccination (Sinopharm and Pfizer-BioNTech)","author":"Hamed","year":"2022","journal-title":"Hum. Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2023.03.002_b0325","doi-asserted-by":"crossref","DOI":"10.3390\/biom12050604","article-title":"Matrix metalloproteinases on severe COVID-19 lung disease pathogenesis: cooperative actions of MMP-8\/MMP-2 axis on immune response through HLA-G shedding and oxidative stress","volume":"12","author":"da Silva-Neto","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.humimm.2023.03.002_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105550","article-title":"The association of decreased HLA-G(+) immune cell frequencies with critical COVID-19 patients","volume":"167","author":"Ramzannezhad","year":"2022","journal-title":"Microb Pathog"},{"issue":"9","key":"10.1016\/j.humimm.2023.03.002_b0335","doi-asserted-by":"crossref","DOI":"10.3390\/v13091855","article-title":"Increased sHLA-G is associated with improved COVID-19 outcome and reduced neutrophil adhesion","volume":"13","author":"Bortolotti","year":"2021","journal-title":"Viruses"},{"issue":"17","key":"10.1016\/j.humimm.2023.03.002_b0340","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179736","article-title":"The severity of COVID-19 affects the plasma soluble levels of the immune checkpoint HLA-G molecule","volume":"23","author":"Cordeiro","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.humimm.2023.03.002_b0345","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.cmi.2021.01.012","article-title":"SARS-CoV-2 nucleocapsid protein and ultrastructural modifications in small bowel of a 4-week-negative COVID-19 patient","volume":"27","author":"Rizzo","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"issue":"7848","key":"10.1016\/j.humimm.2023.03.002_b0350","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-020-03065-y","article-title":"Genetic mechanisms of critical illness in COVID-19","volume":"591","author":"Pairo-Castineira","year":"2021","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.humimm.2023.03.002_b0355","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s00018-022-04592-9","article-title":"Induction of pulmonary HLA-G expression by SARS-CoV-2 infection","volume":"79","author":"Seliger","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.humimm.2023.03.002_b0360","first-page":"28","article-title":"COVID-19 infection in patients with comorbidities: clinical and immunological insight","author":"El-Badawy","year":"2022","journal-title":"Clin. Appl. Thromb.-Hemost."},{"issue":"1\u20132","key":"10.1016\/j.humimm.2023.03.002_b0365","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jim.2004.07.006","article-title":"Comparative analysis of lymphocyte activation marker expression and cytokine secretion profile in stimulated human peripheral blood mononuclear cell cultures: an in vitro model to monitor cellular immune function","volume":"293","author":"Reddy","year":"2004","journal-title":"J. Immunol. Methods"},{"issue":"4","key":"10.1016\/j.humimm.2023.03.002_b0370","doi-asserted-by":"crossref","first-page":"p. 453-+","DOI":"10.1038\/s41591-020-0819-2","article-title":"Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19","volume":"26","author":"Thevarajan","year":"2020","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.humimm.2023.03.002_b0375","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1177\/2031952520934569","article-title":"Covid-19 and labour law in Italy","volume":"11","author":"Biasi","year":"2020","journal-title":"Eur. Labour Law J."},{"issue":"5","key":"10.1016\/j.humimm.2023.03.002_b0380","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jcyt.2018.02.372","article-title":"Mesenchymal stromal cell exosome-enhanced regulatory T-cell production through an antigen-presenting cell-mediated pathway","volume":"20","author":"Zhang","year":"2018","journal-title":"Cytotherapy"},{"key":"10.1016\/j.humimm.2023.03.002_b0385","first-page":"8890434","article-title":"Bone mesenchymal stem cell-derived exosome-enclosed miR-181a induces CD4(+)CD25(+)FOXP3(+) regulatory T cells via SIRT1\/acetylation-mediated FOXP3 stabilization","volume":"2022","author":"Wang","year":"2022","journal-title":"J. Oncol."},{"issue":"6","key":"10.1016\/j.humimm.2023.03.002_b0390","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.humimm.2023.03.002_b0395","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.humimm.2023.03.002_b0400","article-title":"Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patients","author":"Amodio","year":"2022","journal-title":"Andrology"},{"issue":"9","key":"10.1016\/j.humimm.2023.03.002_b0405","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/s41409-018-0145-1","article-title":"Elevated soluble human leukocyte antigen G levels in patients after allogeneic stem cell transplantation are associated with less severe acute and chronic graft-versus-host disease","volume":"53","author":"Kordelas","year":"2018","journal-title":"Bone Marrow Transpl."},{"issue":"21","key":"10.1016\/j.humimm.2023.03.002_b0410","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.3889\/oamjms.2019.830","article-title":"Interleukin 10 induces the expression of membrane-bound HLA- G and the production of soluble HLA-G on HeLa CCL-2 cells","volume":"7","author":"Hasanah","year":"2019","journal-title":"Open Access Maced. J. Med. Sci."},{"issue":"1\u20132","key":"10.1016\/j.humimm.2023.03.002_b0415","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.humimm.2005.12.003","article-title":"Polymorphism in the 5' upstream regulatory and 3' untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression","volume":"67","author":"Hviid","year":"2006","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2023.03.002_b0420","doi-asserted-by":"crossref","first-page":"4587520","DOI":"10.1155\/2017\/4587520","article-title":"Hypoxic modulation of HLA-G expression through the metabolic sensor HIF-1 in human cancer cells","volume":"2017","author":"Garziera","year":"2017","journal-title":"J. Immunol. Res."},{"issue":"22","key":"10.1016\/j.humimm.2023.03.002_b0425","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228678","article-title":"The molecular and functional characteristics of HLA-G and the interaction with its receptors: where to intervene for cancer immunotherapy?","volume":"21","author":"Attia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.humimm.2023.03.002_b0430","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0198-8859(02)00821-2","article-title":"Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules","volume":"64","author":"Menier","year":"2003","journal-title":"Hum. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2023.03.002_b0435","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.4049\/jimmunol.1300438","article-title":"Binding of HLA-G to ITIM-bearing Ig-like transcript 2 receptor suppresses B cell responses","volume":"192","author":"Naji","year":"2014","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2023.03.002_b0440","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/tan.14725","article-title":"Genetic diversity of the LILRB1 and LILRB2 coding regions in an admixed Brazilian population sample","volume":"100","author":"Oliveira","year":"2022","journal-title":"HLA"},{"key":"10.1016\/j.humimm.2023.03.002_b0445","first-page":"46","article-title":"Modulation of the inhibitory receptor leukocyte Ig-like receptor 1 on human natural killer cells","volume":"2","author":"Li","year":"2011","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2023.03.002_b0450","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001998","article-title":"First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G","volume":"9","author":"Anna","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"9","key":"10.1016\/j.humimm.2023.03.002_b0455","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004859","article-title":"BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression","volume":"10","author":"Mandel","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.humimm.2023.03.002_b0460","doi-asserted-by":"crossref","unstructured":"Gilead Buys into Tizona's Anti-HLA-G Strategy, 2020. Cancer Discov. 10(10), 1433.","DOI":"10.1158\/2159-8290.CD-NB2020-077"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885923000435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885923000435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:58:34Z","timestamp":1759319914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885923000435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":92,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0198885923000435"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2023.03.002","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral HLA-G\/ILT-2 immune checkpoint axis in acute and convalescent COVID-19 patients","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2023.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}